Ashrith Guha1, Romain Harmancey, Heinrich Taegtmeyer. 1. Department of Internal Medicine, Division of General Medicine, The University of Texas Medical School at Houston, Houston, Texas 77030, USA.
Abstract
PURPOSE OF REVIEW: Diabetic patients with heart failure have a poor prognosis. Although it has been demonstrated in animal models that metabolic maladaptation plays a pivotal role in contractile dysfunction of the heart, the understanding of 'diabetic cardiomyopathy' and its treatment in humans remains incomplete. RECENT FINDINGS: Epidemiological studies show that structural changes in the left ventricle can be demonstrated before onset of clinical diabetes. Diastolic dysfunction is the earliest manifestation that is associated with increasing level of serum-free fatty acids and worsening glycemic control. Spectroscopic and histologic evidence in the human myocardium indicates a maladaptive metabolic response in diabetes, characterized by intramyocellular triglyceride accumulation. Studies also suggest a link between myocardial isoform switching, calcium homeostasis and altered metabolism in the development of heart failure. However, treatment directed at deranged metabolic control in diabetes is effective only in animals, and not in humans. SUMMARY: Although clinical studies suggest the existence of 'diabetic cardiomyopathy', it is still difficult to prove causality. However, animal models and human studies suggest that systemic metabolic derangements may lead to metabolic, functional and structural maladaptation of the heart. The exact mechanisms of heart failure in diabetes remain elusive.
PURPOSE OF REVIEW: Diabeticpatients with heart failure have a poor prognosis. Although it has been demonstrated in animal models that metabolic maladaptation plays a pivotal role in contractile dysfunction of the heart, the understanding of 'diabetic cardiomyopathy' and its treatment in humans remains incomplete. RECENT FINDINGS: Epidemiological studies show that structural changes in the left ventricle can be demonstrated before onset of clinical diabetes. Diastolic dysfunction is the earliest manifestation that is associated with increasing level of serum-free fatty acids and worsening glycemic control. Spectroscopic and histologic evidence in the human myocardium indicates a maladaptive metabolic response in diabetes, characterized by intramyocellular triglyceride accumulation. Studies also suggest a link between myocardial isoform switching, calcium homeostasis and altered metabolism in the development of heart failure. However, treatment directed at deranged metabolic control in diabetes is effective only in animals, and not in humans. SUMMARY: Although clinical studies suggest the existence of 'diabetic cardiomyopathy', it is still difficult to prove causality. However, animal models and human studies suggest that systemic metabolic derangements may lead to metabolic, functional and structural maladaptation of the heart. The exact mechanisms of heart failure in diabetes remain elusive.
Authors: Mehdi H Shishehbor; Byron J Hoogwerf; Paul Schoenhagen; Steven P Marso; Jing P Sun; Jianbo Li; Allan L Klein; James D Thomas; Mario J Garcia Journal: Am J Cardiol Date: 2003-06-15 Impact factor: 2.778
Authors: C Depre; M E Young; J Ying; H S Ahuja; Q Han; N Garza; P J Davies; H Taegtmeyer Journal: J Mol Cell Cardiol Date: 2000-06 Impact factor: 5.000
Authors: Norbert Fülöp; Meredith M Mason; Kaushik Dutta; Peipei Wang; Amy J Davidoff; Richard B Marchase; John C Chatham Journal: Am J Physiol Cell Physiol Date: 2006-11-29 Impact factor: 4.249
Authors: Dean T Eurich; Finlay A McAlister; David F Blackburn; Sumit R Majumdar; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson Journal: BMJ Date: 2007-08-30
Authors: Michaela Scheuermann-Freestone; Per L Madsen; David Manners; Andrew M Blamire; Robin E Buckingham; Peter Styles; George K Radda; Stefan Neubauer; Kieran Clarke Journal: Circulation Date: 2003-06-16 Impact factor: 29.690
Authors: Sanda Despa; Kenneth B Margulies; Le Chen; Anne A Knowlton; Peter J Havel; Heinrich Taegtmeyer; Donald M Bers; Florin Despa Journal: Circ Res Date: 2012-01-24 Impact factor: 17.367
Authors: Sarah Brice Russo; Catalin F Baicu; An Van Laer; Tuoyu Geng; Harinath Kasiganesan; Michael R Zile; L Ashley Cowart Journal: J Clin Invest Date: 2012-11 Impact factor: 14.808
Authors: Giovanni de Simone; Richard B Devereux; Marcello Chinali; Elisa T Lee; James M Galloway; Ana Barac; Julio A Panza; Barbara V Howard Journal: J Hypertens Date: 2010-02 Impact factor: 4.844
Authors: Kathleen Guglielmino; Kaleena Jackson; Todd R Harris; Vincent Vu; Hua Dong; Gavin Dutrow; James E Evans; James Graham; Bethany P Cummings; Peter J Havel; Nipavan Chiamvimonvat; Sanda Despa; Bruce D Hammock; Florin Despa Journal: Am J Physiol Heart Circ Physiol Date: 2012-08-03 Impact factor: 4.733
Authors: Magnus T Jensen; Peter Sogaard; Ida Gustafsson; Jan Bech; Thomas F Hansen; Thomas Almdal; Simone Theilade; Tor Biering-Sørensen; Peter G Jørgensen; Søren Galatius; Henrik U Andersen; Peter Rossing Journal: Diabetologia Date: 2019-10-30 Impact factor: 10.122